The PCT of 0.2 ng/mL represented the optimal cut-point for the two clinically important outcomes, all-cause mortality and mechanical ventilation, especially for moderate to severe COVID-19 patients with PCT measured within 3 days following admission. The gene discussed is CALCA; the disease is COVID-19.